Breaking News

Plenaries Discuss AI and Next-Gen Modality Development at AAPS NBC

Scientific program to cover Advances in Discovery, Formulation, and Delivery of New Modalities and Novel Strategies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AAPS announced the opening and closing plenary speakers for the 2024 National Biotechnology Conference (NBC), taking place May 13-16 in San Francisco, CA.    Hari Pujar, Ph.D., M.B.A., Chief Operating Officer of Tessera Therapeutics and Operating Partner at Flagship Pioneering, will deliver the opening plenary on Monday, May 13, at 3 p.m. He will discuss next-generation approaches to biotechnology modality development.   Dr. Pujar is a global biopharmaceutical executive with ov...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters